Brasil Pharma (BSP:BPHA3) Operating Income : R$-23.59 Mil (TTM As of Mar. 2019)

View and export this data going back to 2011. Start your Free Trial

What is Brasil Pharma Operating Income?

Brasil Pharma's Operating Income for the three months ended in Mar. 2019 was R$-6.22 Mil. Its Operating Income for the trailing twelve months (TTM) ended in Mar. 2019 was R$-23.59 Mil.

Operating Margin % is calculated as Operating Income divided by its Revenue. Brasil Pharma's Operating Income for the three months ended in Mar. 2019 was R$-6.22 Mil. Brasil Pharma's Revenue for the three months ended in Mar. 2019 was R$1.64 Mil. Therefore, Brasil Pharma's Operating Margin % for the quarter that ended in Mar. 2019 was -378.28%.

Brasil Pharma's 5-Year average Growth Rate for Operating Margin % was 0.00% per year.

Operating Income or EBIT is linked to Return on Capital for both regular definition and Joel Greenblatt's definition. Brasil Pharma's annualized ROC % for the quarter that ended in Mar. 2019 was -29.93%. Brasil Pharma's annualized ROC (Joel Greenblatt) % for the quarter that ended in Mar. 2019 was %.

Brasil Pharma Operating Income Historical Data

The historical data trend for Brasil Pharma's Operating Income can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Brasil Pharma Operating Income Chart

Brasil Pharma Annual Data

Trend

Dec10

Dec11

Dec12

Dec13

Dec14

Dec15

Dec16

Dec17

Dec18

Operating Income

Get a 7-Day Free Trial

-513.74

-173.15

-317.74

-235.07

-24.74

Brasil Pharma Quarterly Data
	Jun14	Sep14	Dec14	Mar15	Jun15	Sep15	Dec15	Mar16	Jun16	Sep16	Dec16	Mar17	Jun17	Sep17	Dec17	Mar18	Jun18	Sep18	Dec18	Mar19
Operating Income	Get a 7-Day Free Trial															-7.36	-6.73	-5.93	-4.71	-6.22

Brasil Pharma Operating Income Calculation

Operating Income, is the profit a company earned through operations. All expenses, including cash expenses such as cost of goods sold (COGS), research & development, wages, and non-cash expenses, such as depreciation, depletion and amortization, have been deducted from the sales.

Operating Income for the trailing twelve months (TTM) ended in Mar. 2019 adds up the quarterly data reported by the company within the most recent 12 months, which was R$-23.59 Mil.

Brasil Pharma (BSP:BPHA3) Operating Income Explanation

1. Operating Income or EBIT is linked to Return on Capital for both regular definition and Joel Greenblatt's definition.

Brasil Pharma's annualized ROC % for the quarter that ended in Mar. 2019 is calculated as:

	ROC % (Q: Mar. 2019 )
=	NOPAT	/	Average Invested Capital
=	Operating Income * ( 1 - Tax Rate % )	/	( (Invested Capital (Q: Dec. 2018 )	+	Invested Capital (Q: Mar. 2019 ))	/ count )
=	-24.876 * ( 1 - 0% )	/	( (85.018	+	81.212)	/ 2 )
=	-24.876	/	83.115
=	-29.93 %

where

	Invested Capital		(Q: Dec. 2018 )
=	Total Assets	-	Accounts Payable & Accrued Expense	-	Excess Cash
=	Total Assets	-	Accounts Payable & Accrued Expense	-	( Cash, Cash Equivalents, Marketable Securities	-	max(0, Total Current Liabilities	-	Total Current Assets	+	Cash, Cash Equivalents, Marketable Securities	))
=	72.15	-	166.592	-	( 1.152	-	max(0, 190.905	-	11.445	+	1.152	))
=	85.018

	Invested Capital		(Q: Mar. 2019 )
=	Total Assets	-	Accounts Payable & Accrued Expense	-	Excess Cash
=	Total Assets	-	Accounts Payable & Accrued Expense	-	( Cash, Cash Equivalents, Marketable Securities	-	max(0, Total Current Liabilities	-	Total Current Assets	+	Cash, Cash Equivalents, Marketable Securities	))
=	70.49	-	172.55	-	( 0.809	-	max(0, 194.478	-	11.206	+	0.809	))
=	81.212

Note: The Operating Income data used here is four times the quarterly (Mar. 2019) data.

2. Joel Greenblatt's definition of Return on Capital:

Brasil Pharma's annualized ROC (Joel Greenblatt) % for the quarter that ended in Mar. 2019 is calculated as:

	ROC (Joel Greenblatt) %		(Q: Mar. 2019 )
=	EBIT	/	Average of (Net fixed Assets	+	Net Working Capital)
=	EBIT	/	Average of (Property, Plant and Equipment	+	Net Working Capital)
			Q: Dec. 2018		Q: Mar. 2019
=	EBIT	/	( ( (Property, Plant and Equipment + Net Working Capital)	+	(Property, Plant and Equipment + Net Working Capital) )	/	count )
=	-94.832	/	( ( (0 + max(-165.242, 0))	+	(0 + max(-168.678, 0)) )	/	2 )
=	-94.832	/	( ( 0	+	0 )	/	2 )
=	-94.832	/	0
=	%

where Working Capital is:

	Working Capital		(Q: Dec. 2018 )
=	(Accounts Receivable	+	Total Inventories	+	Other Current Assets)	-	(Accounts Payable & Accrued Expense	+	Defer. Rev.	+	Other Current Liabilities)
=	(1.467	+	0	+	8.826)	-	(166.592	+	0	+	8.943)
=	-165.242

	Working Capital		(Q: Mar. 2019 )
=	(Accounts Receivable	+	Total Inventories	+	Other Current Assets)	-	(Accounts Payable & Accrued Expense	+	Defer. Rev.	+	Other Current Liabilities)
=	(1.742	+	0	+	8.655)	-	(172.55	+	0	+	6.525)
=	-168.678

When net working capital is negative, 0 is used.

Note: The EBIT data used here is four times the quarterly (Mar. 2019) EBIT data.

3. Operating Income is also linked to Operating Margin %:

Brasil Pharma's Operating Margin % for the quarter that ended in Mar. 2019 is calculated as:

Operating Margin %	=	Operating Income (Q: Mar. 2019 )	/	Revenue (Q: Mar. 2019 )
	=	-6.219	/	1.644
	=	-378.28 %

4. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Operating Income growth rate using Operating Income per share data.

Be Aware

Compared with a company's EBITDA margin, Operating Margin can be manipulated by adjusting the rate of depreciation, depletion and amortization (DDA).

If a company is facing competition, its Operating Margin may decline. Often the Operating Margin declines well before the company's revenue or even profit decline. Therefore, Operating Margin is a very important indicator of whether the company is facing problems.

For instance, by 2012, Nokia (NOK)'s problems were well known and its stock had lost more than 90% of its market value since 2007. But Nokia's Operating Margin had already been in decline since 2002, although its earnings per share were still rising. Investors who paid attention to Operating Margin would have avoided this huge loss. The same can be said for Research-in-Motion (RIMM).

Therefore, Operating Margin is a very important screening filter for GuruFocus. GuruFocus's Buffett-Munger screener requires that the profit margin is either consistent or expanding. The Model Portfolio of the Buffett-Munger screener has outperformed the market every year since inception in 2009.

Brasil Pharma Operating Income Related Terms

Thank you for viewing the detailed overview of Brasil Pharma's Operating Income provided by GuruFocus.com. Please click on the following links to see related term pages.

Brasil Pharma (BSP:BPHA3) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Brasil Pharma SA (BSP:BPHA3) » Definitions » Operating Income

Comparable Companies

Traded in Other Exchanges

N/A

Address

Avenida Presidente Juscelino Kubitschek, 1,830, 3rd floor, Itaim Bibi, Sao Paulo, SP, BRA, 04543-900

Website

http://www.brasilpharma.com.br

Brasil Pharma SA is a Brazil-based company primarily engaged in the pharmaceutical retail sector. The company operates in the retail sale of medicines, perfumes, cosmetics, skincare and beauty products and toiletries. The operating segments of the company are Retail sector and Service sector, of which majority of the revenue is generated from the Retail segment. The group has its presence in all the regions of Brazil through its own stores and a franchise network. The owned stores of the company are operated under the Big Ben, Guararapes, District Pharmacy Rosary, Sant'Ana and Mais Economica brands. The company's franchises operate under the Farmais brand.

Brasil Pharma (BSP:BPHA3) Headlines

No Headlines